Clinical Trial Update: An Investigation Of The Interaction Of GSK961081 With Inhaled Beta-Agonist And Anti-Muscarinic Drugs. [Phase 2]

View source ↗

Summary

Phase 2 trial investigating interaction of GSK961081 with inhaled beta-agonist and antimuscarinic drugs in chronic obstructive pulmonary disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• GSK961081

Snippet

Sponsor: Theravance Biopharma | Conditions: Pulmonary Disease, Chronic Obstructive | Phase 2 | Status: COMPLETED | Results posted: 2017-03-27